Veronica Lambrechts serves as the Senior Manager of Commercial Decision Science - Digital, Technology & Innovation at Amgen, where she leverages her extensive expertise in artificial intelligence (AI) and machine learning (ML) to drive transformative initiatives within the organization. With over a decade of experience...
Veronica Lambrechts serves as the Senior Manager of Commercial Decision Science - Digital, Technology & Innovation at Amgen, where she leverages her extensive expertise in artificial intelligence (AI) and machine learning (ML) to drive transformative initiatives within the organization. With over a decade of experience in analytics and statistics, Veronica has been instrumental in developing and executing a comprehensive technology roadmap that enhances Amgen's advanced data and analytics (D&A) capabilities. Her leadership in orchestrating a sophisticated 17-model marketing video rendering system showcases her ability to apply cutting-edge ML algorithms to real-world challenges, ultimately delivering impactful insights that inform strategic decision-making.
In her current role, Veronica excels in cross-functional collaboration, working closely with Data Architects, Business Subject Matter Experts (SMEs), and Data Scientists to design and maintain robust data pipelines and scalable MLOps capabilities. This collaborative approach ensures that high-performance algorithms are effectively managed and deployed, driving efficiency and innovation across the organization. Her proficiency in business analytics, creative problem solving, and market research empowers her to navigate complex datasets and extract actionable insights that support Amgen’s commercial objectives.
Bilingual in English and Spanish, Veronica also excels in client engagement, fostering strong relationships that enhance communication and collaboration. Her diverse skill set, which includes expertise in SAS, SQL, and economics, positions her as a key player in Amgen's mission to harness data-driven strategies for improved patient outcomes and market success. As she continues to push the boundaries of AI and ML applications in the biopharmaceutical industry, Veronica remains committed to advancing the field of commercial decision science through innovation and strategic foresight.
